Literature DB >> 2216459

Amplification of the c-myc and the pvt-like region in human multiple myeloma.

M H Bakkus1, K M Brakel-van Peer, J J Michiels, M B van 't Veer, R Benner.   

Abstract

Genetic alterations that lead to the clonal expansion of differentiated cells in multiple myeloma have still to be elucidated. Many chromosomal aberrations have been found, but until now, none of them is typically associated with multiple myeloma. In search for genetic defects in multiple myeloma we studied the structure and expression of the c-myc oncogene and the pvt-like region because of their frequent association with other B-cell malignancies. Here we report co-amplification of the c-myc oncogene and the 5' part of the pvt-like region in two out of 26 cases of multiple myeloma. In both cases only kappa-light chains were produced. The amplification also manifested itself at the RNA level. Total RNA was analysed in one of these two cases showing abundant c-myc mRNA. In the same RNA sample we also detected a strong hybridizing band of about 7 kb, when the pSS.4 probe, representing the 5' part of the pvt-like region, was used. This band was not present in total RNA from normal bone marrow cells or bone marrow from multiple myeloma patients without the amplification of c-myc and the pvt-like region. Until now, transcripts of the pvt-like region were only found in a few human cell lines ranging in size from 1 to 11 kb. This is the first case in which a high expression of a +/- 7 kb transcript of the pvt-like region has been found in freshly obtained tumor material probably due to a pvt-amplification. The occurrence of abnormalities in the c-myc and the pvt-like region in multiple myeloma is a rare event and may be associated with the progression of this type of tumor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216459

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Proto-oncogene analysis in multiple myeloma.

Authors:  M Ladanyi; S Wang; R Niesvizky; H Feiner; J Michaeli
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

2.  Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

Authors:  Y Shou; M L Martelli; A Gabrea; Y Qi; L A Brents; A Roschke; G Dewald; I R Kirsch; P L Bergsagel; W M Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.

Authors:  Yuhei Kamada; Mamiko Sakata-Yanagimoto; Masashi Sanada; Aiko Sato-Otsubo; Terukazu Enami; Kazumi Suzukawa; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Yasushi Okoshi; Yuichi Hasegawa; Seishi Ogawa; Shigeru Chiba
Journal:  Int J Hematol       Date:  2012-09-13       Impact factor: 2.490

4.  A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.

Authors:  Kerstin B Meyer; Ana-Teresa Maia; Martin O'Reilly; Maya Ghoussaini; Radhika Prathalingam; Patricia Porter-Gill; Stefan Ambs; Ludmila Prokunina-Olsson; Jason Carroll; Bruce A J Ponder
Journal:  PLoS Genet       Date:  2011-07-21       Impact factor: 5.917

5.  The 8q24 gene desert: an oasis of non-coding transcriptional activity.

Authors:  Konrad Huppi; Jason J Pitt; Brady M Wahlberg; Natasha J Caplen
Journal:  Front Genet       Date:  2012-04-30       Impact factor: 4.599

6.  A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).

Authors:  Victor Enciso-Mora; Peter Broderick; Yussanne Ma; Ruth F Jarrett; Henrik Hjalgrim; Kari Hemminki; Anke van den Berg; Bianca Olver; Amy Lloyd; Sara E Dobbins; Tracy Lightfoot; Flora E van Leeuwen; Asta Försti; Arjan Diepstra; Annegien Broeks; Jayaram Vijayakrishnan; Lesley Shield; Annette Lake; Dorothy Montgomery; Eve Roman; Andreas Engert; Elke Pogge von Strandmann; Katrin S Reiners; Ilja M Nolte; Karin E Smedby; Hans-Olov Adami; Nicola S Russell; Bengt Glimelius; Stephen Hamilton-Dutoit; Marieke de Bruin; Lars P Ryder; Daniel Molin; Karina Meden Sorensen; Ellen T Chang; Malcolm Taylor; Rosie Cooke; Robert Hofstra; Helga Westers; Tom van Wezel; Ronald van Eijk; Alan Ashworth; Klaus Rostgaard; Mads Melbye; Anthony J Swerdlow; Richard S Houlston
Journal:  Nat Genet       Date:  2010-10-31       Impact factor: 38.330

Review 7.  Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.

Authors:  Martina Ghetti; Ivan Vannini; Clelia Tiziana Storlazzi; Giovanni Martinelli; Giorgia Simonetti
Journal:  Mol Cancer       Date:  2020-03-30       Impact factor: 27.401

8.  Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression.

Authors:  Hiroshi Handa; Kazuki Honma; Tsukasa Oda; Nobuhiko Kobayashi; Yuko Kuroda; Kei Kimura-Masuda; Saki Watanabe; Rei Ishihara; Yuki Murakami; Yuta Masuda; Ken-Ichi Tahara; Hisashi Takei; Tetsuhiro Kasamatsu; Takayuki Saitoh; Hirokazu Murakami
Journal:  Int J Mol Sci       Date:  2020-09-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.